ProShares Bitcoin ETF vs BioNTech SE - ADR — how do they compare? ProShares Bitcoin ETF trades at $8.78, while BioNTech SE - ADR trades at $89.76 (market cap $22.78B). The key difference: BioNTech SE - ADR is trading nearer its 52-week high, ProShares Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| BITO | BNTX | |
|---|---|---|
Sector | Crypto-linked | Health |
52-Week High | $22.93 | $119.34 |
52-Week Low | $7.98 | $83.89 |
Market Cap | — | $22.78B |
Enterprise Value | — | $6.45B |
Trailing returns across standard periods
Latest headlines on both assets
BITO offers exposure to Bitcoin returns primarily through Bitcoin futures contracts. It provides a regulated way for investors to trade Bitcoin performance within a traditional brokerage account without direct ownership.
Read more on BITO →BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →